Compounds, compositions, and methods for control of hepatitis C viral infections
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 19, 2014
Grant Date -
Oct 27, 2011
app pub date -
Oct 29, 2009
filing date -
Oct 29, 2008
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
Various tetrahydropyrazolo[1,5-a]pyrimidine compounds, compositions, methods of making, and methods for the prevention and treatment of HCV infections and associated diseases are disclosed. The invention further relates to biomarkers for identification of HCV strains which are resistant to the tetrahydropyrazolo[1,5-a]pyrimidine compounds.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully